Surgical explantation of the HeartMate 3: step-by-step technique and insights from recent clinical experience
Visual and annotated summary of a surgical tutorial video on the explantation of the HeartMate 3 during orthotopic heart transplantation, complemented by recent evidence on surgical approaches, explant techniques, and clinical outcomes.
Suture or combination with collagen plug? the ACCESS-TAVI trial on vascular closure following transfemoral TAVI
Critical analysis of the randomized ACCESS-TAVI trial, published in the European Heart Journal, which compares two femoral closure strategies after transfemoral TAVI.
Transfemoral TAVR implantation: are we arriving too late?
Results from the first randomized trial assessing transfemoral TAVR in patients with moderate aortic stenosis and ventricular dysfunction.
Long-term outcomes of surgical repair in degenerative mitral regurgitation: the Italian job
This retrospective study analyzed more than three thousand patients who underwent surgical mitral valve repair for degenerative mitral regurgitation, with a 10-year follow-up.
When to operate in type A aortic dissection with malperfusion syndrome?
This article proposes an optimized management strategy for patients with type A aortic dissection complicated by malperfusion syndrome (MPS), structured around a 6-hour threshold from symptom onset.
How has europe evolved over the past 25 years in congenital heart surgery?
Surgical outcomes from the past 25 years of the European Congenital Heart Surgeons Association Congenital Cardiac Database
Alternatives for unreparable aortic valves in pediatric patients: Ross vs Ozaki
Retrospective study comparing outcomes of the Ross and Ozaki techniques in patients with unreparable aortic valve disease.
Double mammary artery in coronary revascularization: in situ or not in situ—is that the question?
This retrospective study evaluated the relationship between graft configuration in double internal thoracic artery (ITA) coronary artery bypass grafting (CABG) and the incidence of major adverse cardiovascular events (MACEs), as well as graft patency.
